000 01494 a2200421 4500
005 20250516092118.0
264 0 _c20120816
008 201208s 0 0 eng d
022 _a1090-2104
024 7 _a10.1016/j.bbrc.2012.04.132
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aLanz, Henriƫtte L
245 0 0 _aProteasomal insensitivity of apoptin in tumor cells.
_h[electronic resource]
260 _bBiochemical and biophysical research communications
_cMay 2012
300 _a169-73 p.
_bdigital
500 _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't
650 0 4 _aAntineoplastic Agents
_xpharmacology
650 0 4 _aBoronic Acids
_xpharmacology
650 0 4 _aBortezomib
650 0 4 _aCapsid Proteins
_xgenetics
650 0 4 _aCell Line
650 0 4 _aCell Line, Tumor
650 0 4 _aFibroblasts
_xmetabolism
650 0 4 _aHumans
650 0 4 _aMutation
650 0 4 _aNeoplasms
_xmetabolism
650 0 4 _aPhosphorylation
650 0 4 _aProteasome Endopeptidase Complex
_xmetabolism
650 0 4 _aProtein Stability
650 0 4 _aProteolysis
650 0 4 _aPyrazines
_xpharmacology
650 0 4 _aTumor Suppressor Protein p53
_xmetabolism
700 1 _aSuijker, Johnny
700 1 _aNoteborn, Mathieu H M
700 1 _aBackendorf, Claude
773 0 _tBiochemical and biophysical research communications
_gvol. 422
_gno. 1
_gp. 169-73
856 4 0 _uhttps://doi.org/10.1016/j.bbrc.2012.04.132
_zAvailable from publisher's website
999 _c21771391
_d21771391